Founded Year
2001Stage
Acquired | AcquiredTotal Raised
$16.02MAbout Cellartis
Provider of human embryonic stem (hES) cell-based products and technologies. The company provides characterized hES cell lines, culture media, tools, feeder cells, and training courses to clinical researchers worldwide. Its primary focus is on drug discovery applications and toxicity testing based on hES cells.
Cellartis Headquarter Location
Biotech Center Arvid Wallgrens Backe 20
Gothenburg, 413 46,
Sweden
46 31 758 09 00
Cellartis Patents
Cellartis has filed 3 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/18/2008 | 2/10/2015 | Drug discovery, Developmental biology, Embryology, Transcription factors, Stem cells | Grant | |
Application Date | 7/18/2008 | ||
|---|---|---|---|
Grant Date | 2/10/2015 | ||
Title | |||
Related Topics | Drug discovery, Developmental biology, Embryology, Transcription factors, Stem cells | ||
Status | Grant |